This study emphasises the potential of NOX as an effective therapeutic target in FLT3-ITD expressing AML, as inhibition and deglycosylation of NOX4 and NOX4D can decrease the levels of H2O2 and DNA damage that would otherwise contribute to genetic instability. This evidence concerns the gene NOX4 and acute myeloid leukemia.